Quantitative PET and histology of brain biopsy reveal lack of selective pittsburgh compound-b binding to intracerebral amyloidoma

  • Colin Groot*
  • , Nelleke Tolboom
  • , Milos D. Ikonomovic
  • , Adriaan A. Lammertsma
  • , Baayla D.C. Boon
  • , Frederik Barkhof
  • , Philip Scheltens
  • , William E. Klunk
  • , Annemieke J.M. Rozemuller
  • , Rik Ossenkoppele
  • , Bart N.M. Van Berckel
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

This single case study examines selective Pittsburgh compound-B (PiB) binding to an intracerebral light-chain amyloidoma using a 90-minute dynamic [ 11 C]PiB-PET scan and brain biopsy tissue. Parametric non-displaceable binding potential (BP ND) images showed low specific binding in the amyloidoma (BP ND = 0.23), while relative tracer delivery was adequate (R 1 = 0.44). Histology of the tissue revealed strong coloring with Congo-red, thioflavin-S, and X-34, indicating presence of amyloid. However, immunological staining with 6F/3D revealed absence of amyloid-β and histofluorescence of 6-CN-PiB, a highly fluorescent derivative of PiB, was at background levels. Our results suggest that PiB does not detect the atypical amyloid pathology associated with an intracerebral light-chain amyloidoma. These findings are of interest to clinicians and researchers applying [ 11 C]PiB-PET to detect atypical forms of amyloid pathology.

Original languageEnglish
Pages (from-to)71-77
Number of pages7
JournalJournal of Alzheimer's Disease
Volume65
Issue number1
DOIs
Publication statusPublished - 1 Jan 2018
Externally publishedYes

Keywords

  • Amyloid
  • case study
  • histology
  • positron emission tomography

Fingerprint

Dive into the research topics of 'Quantitative PET and histology of brain biopsy reveal lack of selective pittsburgh compound-b binding to intracerebral amyloidoma'. Together they form a unique fingerprint.

Cite this